Dr. Daniel Bruce Takeda, MD

Dr. Takeda practices at Adventist Health Physicians Network in Simi Valley, California.

Dr. Takeda's NPI, 1124120977, was assigned on September 2, 2006. Dr. Takeda graduated from David Geffen School of Medicine at UCLA in 1983. Dr. Takeda holds California license G54086.

Dr. Takeda's primary practice is Adventist Health Physicians Network, at 2876 Sycamore Dr, Simi Valley, CA 93065 in Ventura County. The practice phone is (805) 955-8030.

Dr. Takeda's primary practice is Adventist Health Physicians Network in Simi Valley, California. Dr. Takeda is also affiliated with Adventist Health Simi Valley. The medical group on file is Adventist Health Physicians Network. Dmand AI also links Dr. Takeda to 2 more home health agencies, 1 group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Takeda practices, 5 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Takeda's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Takeda is board certified in family medicine by the American Board of Family Medicine. Dr. Takeda is licensed in California.

Dmand AI lists acid reflux, acute gastroduodenitis, acute sinusitis, acute skin infection, alcohol use disorders, aneurysm, anxiety and asthma among the conditions Dr. Takeda treats.

CMS data shows 1,749 Medicare services from Dr. Takeda across 15 procedure codes in 2024, for 361 Medicare patients. Medicare paid $115,223 for them. Every service was in an office.

CMS counts 361 Medicare patients who saw Dr. Takeda in 2024. The largest group is 65 to 74, with 203 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 7% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Takeda's median patient age at 68, with 46% women.

In 2024, Dr. Takeda wrote 3,607 Medicare Part D claims for 340 patients. 91% of them were for generic drugs. CMS names the drug for 3,070 of them, across 64 drugs with 11 or more claims each, at $208,666 in total drug cost. In 2023, CMS named 2,966 claims across 70 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Takeda for performance year 2024, reported through an alternative payment model (APM). Dr. Takeda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Takeda as offering telehealth.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 10 general payments to Dr. Takeda from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Myriad Women's Health, Inc. paid the most, $67.

Dmand AI lists 2 awards for Dr. Takeda, most recently CMS Stage 1 EHR in 2012.

Dr. Takeda graduated from David Geffen School of Medicine at UCLA in 1983.

Dr. Takeda is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.